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Abstract
Introduction: Intraoperative bleeding, one of the major
complications of conventional transurethral resection of
the prostate (TURP), has led to a search for various alter-
native methods of tissue ablation in patients with benign
prostatic hyperplasia. In 1996, we introduced the newly
designed Band Electrode, which combines a high degree
of resection efficiency with a better hemostasis. Material
and Methods: 265 consecutive patients with prostatism
underwent TURP with the Band Electrode. This modified
loop electrode does not consist of a thin wire but is rather
a flat metal band with a width of 1.2 mm. International
prostate symptom score (IPSS), Life Quality Index (L),
peak urine flow and postvoid residual urine were evalu-
ated pre- and postoperatively. Additionally, electrical pa-
rameters have been recorded with a specially designed
high-frequency generator. Results: Median IPSS de-
creased from 23 preoperatively to 8 and 9 at 12 (n = 194)
and 24 months (n = 172), respectively (p ! 0.001). Life
Quality Index (L) dropped from 4 to 2 and 2, respectively
(p ! 0.001). Peak urine flow increased from 8.2 ml/s to
18.2 (at postoperative day 3), 17.8 and 17.4 ml/s, respec-
tively (p ! 0.001). Median postvoid residual urine de-
creased from 77 to 15, 22 and 21 ml, respectively (p !
0.001). Resected tissue mass averaged 25 (8–102) g,
resection time was 36.5 (18–82) min. Indwelling cathe-
ters were removed 32 (24–72) h postoperatively. None of
the patients required blood transfusions or showed signs
of a TUR syndrome. Despite a 1.3 times higher power
need, the total energy application in vivo was compara-
ble to conventional TURP. Conclusions: This simple ex-
change of active electrodes leads to a superior hemosta-
sis and thus safety in TURP. Resection speed, tissue abla-
tion and total energy need remain identical.
Copyright © 2004 S. Karger AG, Basel
Introduction
Most experts still regard transurethral resection of the
prostate (TURP) as the surgical ‘golden standard’ treat-
ment for benign prostatic hyperplasia (BPH). However, a
considerably high morbidity rate of 18% has persisted
over the last decades [1]. Intraoperative bleeding is one of
the major complications of TURP and has led to a search
of various alternative methods of prostatic tissue ablation
[2–6], which primarily were sought to provide better
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hemostasis. Of these methods, the different laser proce-
dures [2–4] and the more recently introduced vaporiza-
tion techniques [5] are used most frequently today.
In 1996, we introduced a newly designed resection
loop, the so-called Band Electrode (fig. 1) and reported
preliminary results on the first 30 patients [7]. Herein, we
report our immediate and midterm results of 265 men
treated with this device at our institution. To our knowl-
edge, this study represents the largest series of patients
undergoing TURP with the Band Electrode for the treat-
ment of lower urinary tract symptoms on the basis of
BPH.
Materials and Methods
In a single-center study, we prospectively analyzed 265 consecu-
tive patients with moderate to severe prostatism on the basis of BPH
who underwent transurethral resection of the prostate with the Band
Electrode (Olympus, Winter & Ibe GmbH, Hamburg, Germany)
from November 1996 to June 1999. The operations were performed
by two surgeons. The average age of the patients was 72.3 (54–87)
years. Preoperatively, 38 of these men had indwelling catheters
because of urinary retention. The median prostate volume measured
by transrectal ultrasound (TRUS) was 42 (16–115) ml preopera-
tively. Voiding function was evaluated pre- and postoperatively
through International Prostate Symptom Score (IPSS) and Life Qual-
ity Index (L). Minimum criteria for TURP with the Band Electrode
were urinary retention, a peak flow of less than 12 ml/s and/or urody-
namic signs of obstruction. Diagnostic evaluation consisted of pa-
tient history, general physical examination, digital rectal examina-
tion, uroflowmetry, in selected cases urethrocystogram (suspicion of
urethral stricture) and urodynamic examination (suspicion of neuro-
genic voiding disorder), ultrasound to determine prostate volume
(transrectal) and postvoid residual (suprapubic) and finally laborato-
ry evaluation including prostate-specific antigen.
As described above, the Band Electrode has a width of 1.2 mm, a
thickness of 0.3 mm and a diameter of 7.0 mm (CH 27) (fig. 1). This
loop can be applied to any standard resectoscope. We used a 27 Fr
double-sheath rotating continuous flow resectoscope (Olympus).
Power was supplied by the ERBOTOM ICC 350 (ERBE Elektrome-
dizin, Tübingen, Germany), a high-frequency (HF) generator which
incorporates automatic voltage control (AutoCut) as well as automat-
ic electric arc control (HighCut). In the HighCut setting the generator
delivers a stronger vaporization effect. The system was set to both
modes, depending on the intraoperative findings. The average power
setting was 200 W. However, the unit delivers the precise power
required for cutting, thus avoiding unnecessarily high power levels.
This feature is not depending on resection speed and depth. The HF
voltage, current and power have been recorded by a computer-
assisted device, especially designed for this evaluation. The TURP
procedure was video-monitored by the Olympus Mini-Chip-Camera
OTV S4 (Olympus).
Resection techniques with the Band Electrode differed in no way
from those used with conventional wire loop electrodes. After initial
resection of the middle lobe, the lateral lobes and the ventral region
were resected clockwise from the bladder neck to the verumonta-
Fig. 1. Comparison of the Band Electrode (right) and a conventional
wire loop electrode (left).
num. As a routine, all patients except three with a history of transi-
tional cell carcinoma of the bladder underwent suprapubic cystosto-
my (CH 16) preoperatively. Anaesthesia for the TURP procedure
was spinal or epidural (n = 179) or general (n = 86).
Follow-up included IPSS, Life Quality Index (L), uroflowmetry
and ultrasonic measurement of postvoid residual urine. Additional-
ly, mass of resected tissue, resection time, catheterization time and
hospital days were assessed. Intra- and postoperative blood loss and
circulatory complications were evaluated by pre- and postoperative
hemoglobin, hematocrit and serum sodium levels.
For statistical analysis, the two-tailed unpaired t test between the
different variable parameters was utilized to study unpaired data.
Follow-up was conducted at 3 days (n = 265), 12 months (n = 194)
and 24 months (n = 172) after surgery. The poor participation of
patients at long-term follow-up with only 75% attendance at 12
months is in part due to the German health care system, which does
not routinely cover postsurgical follow-up at our hospital.
Results
The results in efficacy parameters (table 1) were as fol-
lows: median IPSS decreased from 23 (range 15–35) pre-
operatively to 8 (3–16) and 9 (3–16) at 12 and 24 months
after surgery, respectively (p ! 0.001). Likewise, Life
Quality Index (L) dropped from 4 (2–6) to 2 (1–3) and 2
(1–4), respectively (p ! 0.001). As far as urodynamic
changes are concerned, peak urine flow improved from
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Fig. 2. Course of power P (left y-axis) and
energy E (right y-axis) during a typical cut of
2.5 seconds with the Band Electrode (above)
and the standard wire loop (bottom). Both
cuts were recorded on the same patient at
identical cutting speed and depth. Total en-
ergy (power W time) was 270 W (= Joule) for
the Band Electrode, compared to 190 W for
the standard loop.
8.2 (0–13) to 18.2 (11–40) ml/s at the third postoperative
day, and 17.8 (9–35) and 17.4 (8–36) ml/s, respectively
(p ! 0.001). Median postvoid residual urine decreased
from 77 (0–345) to 15 (0–55), 22 (0–80) and 21 (0–95) ml,
respectively (p ! 0.001).
The safety parameters demonstrated the following
transformations: Median hemoglobin changed from 15.5
(13.3–17.0) g/dl preoperatively to 14.3 (10.3–16.0) g/dl
1 h after surgery. One day postoperatively, hemoglobin
was 14.2 (10.8–15.7) g/dl. Hematocrit levels decreased
from 44.1% (40.6–49.2) preoperatively to 40.0% (36.0–
42.6) and 40.2% (36.2–42.9), respectively. Furthermore,
serum sodium changed from 143 (138–150) mmol/l pre-
operatively to 141 (127–143) mmol/l and 141 (131–144)
mmol/l, respectively.
None of the 265 patients required blood transfusions
or showed clinical or laboratory signs of a TUR syn-
drome. Only 4 patients had to be recatheterized tempo-
rarily due to secondary hemorrhage.
Concerning ablation performance, the resected tissue,
weighed instantly after TURP, averaged 25.4 (8–102) g.
The mean resection time was 26.4 (7–75) min. This leads
to an overall ablation rate of 0.96 g/min. Indwelling cathe-
ters were removed 32 (24–72) h postoperatively. Average
stay following TURP was 3.2 (1–8) days. Regarding the
latter, one has to keep in mind that in Germany, most
TURP patients will spend more than 7 days in hospital.
Despite a 1.3 times higher power need, the total energy
application in vivo was comparable to conventional
TURP. For a typical single cut with a duration of more
than 1 s, in vivo measurements of electrical parameters
revealed a power need averaging 100 (85–130) W for the
Band Electrode, compared to 75 (60–105) W for a stan-
dard TURP wire loop (factor 1.3–1.5). Figure 2 demon-
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Table 1. Changes in efficacy parameters after TURP with the Band Electrode
Preop. 3 days 12 months 24 months
(n = 265) (n = 265) (n = 194) (n = 172)
IPSS 22.4 (15–35) – 8.3 (3–16)* 8.4 (3–16)*
Life Quality Index (L) 4.2 (2–6) – 1.9 (1–3)* 1.8 (1–4)*
Peak urine flow, ml/s 8.2 (0–13) 18.2 (11–40)* 17.8 (9–35)* 17.4 (8–36)*
Postvoid residual urine, ml 77 (0–345) 15 (0–55)* 22 (0–80)* 21 (0–95)*
Mass of resected tissue, g 35.3 (10–100)
Operation time, min 36.5 (18–82)
Values given are the median (quartile).
* p ! 0.001.
Table 2. Complications of TURP with the Band Electrode (12-
month follow-up)
Number of patients
(196 total)
Percentage
Blood transfusion 0 0
TUR syndrome 0 0
Urethral stricture 2 1.0
Failure to void 0 0
Urinary tract infection 4 2.0
Epididymitis 1 0.5
Urinary incontinence 0 0
strates the course of power (P) and energy (E) for both
electrodes. To correctly interpret these data, it is essential
to remember that the actual power need does not neces-
sarily correspond to the power setting at the generator. On
account of less electrode activations with the Band Elec-
trode, the total application of energy was equivalent to
standard TURP and averaged approximately 15,000 W
(= Joule) cumulatively, or 500 W per resected gram of tis-
sue.
Despite the higher power application described above,
histological studies were not adversely affected by ther-
mal alterations of resected tissue. In our series, 6 patients
were diagnosed for prostate cancer on the basis of TURP
specimens.
The use of the wider Band Electrode does not lead to a
reduction of the field of vision. The operation site can be
judged as accurately and extensively as with the wire loop
electrode.
Of the 194 patients available for follow-up at 12
months, 2 (1.0%) developed postoperative urethral stric-
tures, which were successfully treated by urethrotomia
interna. None of the patients to date needed reoperation
for bleeding or recurrent voiding dysfunction. The com-
plications are summarized in table 2.
Discussion
The use of the Band Electrode enables the surgeon to
resect hyperplastic prostatic tissue as easily and cleanly as
with the conventional wire loop. The same equipment
and surgical techniques can be applied. However, the
high-frequency generator used in our study permits to car-
ry out the procedure in both, automatic voltage control
mode (AutoCut) as well as automatic electric arc control
mode (HighCut). With the AutoCut setting, the resection
is performed similarly to conventional TURP, whereas
the HighCut setting produces a more vaporization-like
resection (‘Vapo-TURP’). On account of these features,
HighCut was used for the most part of the resection,
whereas AutoCut was mainly employed for resection
close to the apex. As mentioned above, the width of the
metal band does not reduce the surgeon’s vision. The
resection chips obtained with the Band Electrode are
approximately identical in size and shape to those har-
vested with conventional electrodes, since both loops
have a diameter of 7 mm. Histological examination is not
altered by thermal changes. This finding was recently con-
firmed in a study comparing conventional TURP and
TURP with a wider electrode, very similar to the Band
Electrode [8].
Although our data represent preliminary results with a
limited follow-up, the efficacy of the Band Electrode pro-
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Fig. 3. Simplified midline sagittal view of
conventional loop (left) and Band Electrode
(right) during cutting of a blood vessel within
prostatic tissue. Due to the greater width, at
identical resection speed, the Band Electrode
generates a fourfold longer contact surface
between electrode and vessel, resulting in a
superior hemostasis.
0.3 1.2
cedure seems to be equivalent to conventional TURP [1].
This, of course, had to be expected since both techniques
are truly tissue-ablative and leave an identical prostatic
cavity postoperatively.
The subjective impression of considerably reduced
intraoperative bleeding with the use of the Band Electrode
is confirmed by the inessential decrease of serum sodium
and hematocrit levels. The changes of 2.0 mmol/l and
4.1%, respectively, are comparable to those reported for
Nd:YAG laser prostatectomies [9] or vaporization proce-
dures [5]. However, it has to be added critically that these
parameters depend heavily on infusion therapy. Conven-
tional TURP in large series has reportedly been associated
with bleeding requiring blood transfusion in 8.4%, clot
retention in 3.3% and TUR syndrome in 2.1% [10, 11].
None of our 265 patients required transfusions or dis-
played signs of a TUR syndrome.
Both efficacy and safety parameters generated in our
series are well congruent with results of other investiga-
tors, using analogous electrodes in smaller studies [12,
13].
The basis for this superior hemostasis is given by the
shape of the newly designed electrode. Like conventional
wire loop electrodes, the band is approximately 0.3 mm
thick, but its width is nearly 1.2 mm. The duration of elec-
tric current at the vessel being coagulated depends on the
geometry and size of the electrode and on the speed of
cutting. It is proportional to the width of the loop and
reciprocal to the speed of cutting. The additional width of
the Band Electrode results in a prolonged flow of current,
especially into the decisive lateral parts of the prostatic
tissue. Since hemostasis is also a function of conduction
time, this produces a more effective coagulation of tran-
sected bleeding vessels. Every surgeon has experienced
the phenomenon of reduced intraoperative bleeding of
prostatic tissue when resecting very slowly. Enlarging the
width of the electrode from 0.3 to 1.2 mm creates a four-
fold increase in the duration of contact between the elec-
trode and the transected vessels (fig. 3). Thus, in theory
the hemostatic effect can therefore be amplified by a fac-
tor of four when the speed of resection is constant. Repre-
senting even larger surfaces, pure vaporization proce-
dures with roller electrodes perform an even more effi-
cient closure of vessels. However, due to their low abla-
tion efficacy, significantly prolonged activations lead to a
5–10 times higher energy need per removed gram of tissue
[14].
Recording electrical parameters during TURP with the
Band Electrode and a conventional loop showed that the
increase of power and energy applied to the tissue and
adherent structures correlates with the width of the elec-
trode. In our studies the power need in the HighCut mode
averaged approx. 100 W for the Band Electrode, com-
pared to approx. 75 W for the wire loop, representing a 1.3
times higher power application (fig. 2). Concerning each
single cut, this factor is also valid for energy application
since energy is the product of power and time. Concerning
the total energy application per TURP, the 1.3 times high-
er power need of the Band Electrode was totally compen-
sated by a decreased need for selective coagulation of
bleeding vessels.
Nevertheless, the new type of electrode is not capable
of closing every vessel at resection speed. Larger vessels
still have to be coagulated selectively. Due to their width
this is performed more comfortably than with the wire
loop. Remarkably, the risk of inadvertent tissue or cap-
sule perforation is also considerably reduced because of
the greater width of the new device.
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Conclusions
In our experience, the Band Electrode represents an
ideal synthesis of regular transurethral resection of the
prostate (TURP) and the benefits of transurethral vapori-
zation of the prostate (TUVP). Due to its new geometry, it
combines conventional resection efficacy with a superior
hemostasis. In this initial phase II study displaying out-
standing efficacy as well as safety, we showed that the
Band Electrode could play a substantial role in the ongo-
ing effort to raise the golden standard of surgical BPH
treatment.
However, definitive evaluation of this promising de-
vice will require longer follow-up on a larger patient col-
lective. Therefore, randomized clinical trials in a multi-
center setting should be initiated to prospectively com-
pare the Band Electrode with conventional TURP and
TUVP.
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